This study evaluated the effect of ractopamine (RAC) on the performance of finishing pigs and the meat quality of these animals. Seventy crossbred pigs (35 barrows and 35 females) selected for high gain of lean meat, with initial weight of 77.1±0.32 kg were distributed in randomized blocks with five treatments (0, 5, 10, 15, and 20 ppm RAC in the diet) and seven replications during 28 days. The experimental unit was represented by a male and a female pig. Regarding the performance variables, there was a linear increase in final weight with increasing levels of RAC, as well as in average daily weight gain. An improvement in feed conversion was observed for animals fed RAC, and the optimal level - estimated by the LRP model - was ~ 5 ppm. For feed intake, no significant effect on intake of digestible lysine and energy intake was observed. Carcass yield responses increased linearly with the RAC dose. Ash content, color component b* and loss drip linearly decreased with increasing doses of RAC. There was also a significant difference in the percentage of ether extract and crude protein in the loin, and treatment with 20 ppm RAC showed a lower amount of protein and larger amounts of lipids. Moisture content, color component L*, weight loss by cooking and defrosting, shear force and pH were not affected by the treatment. Concerning the lipid oxidation, there was no effect of RAC on the concentration of TBARS (thiobarbituric acid reactive substances) under cooling and under freezing. Thus, all ractopamine levels improve performance compared with control and do not negatively affect the quality of fresh, chilled or frozen pig meat.

The objective of this work was to evaluate the performance of piglets in the nursery phase submitted to activation of immune system with vaccine against Haemophilus parasuis and to different levels of metabolizable energy in the diets. It was used 160 barrows and females at 30 days of age, weaned at 23 days of age, with initial weight of 7.97 ± 0.54 kg, distributed in 2 × 4 factorial arrangement (with vaccination and without vaccination with four levels of metabolizable energy - 3,200; 3,300; 3,400 and 3,500 kcal/kg). Each combination was evaluated with five repetitions of four animals per experimental plot (two males and two females). Energy levels reduced linearly the intake, feed conversion and the total number of leukocytes in blood in the experimental period, regardless of the use of vaccine which in turn reduced daily average weight gain only in the first week after second application and it increased the number of limonocytes and spleen weight after three weeks. There was no difference in the C-reactive protein quantity in the blood in the periods when it was evaluated. The use of vaccine reduces performance immediatelly after its application but after it occurs recovery of performance with changes in the number of monocytes and spleen weight. Dietary energy levels do not smooth this reduction in the performance, but they influence intake, feed conversion and blood parameters in the total period of use.